BOT 1.33% 37.0¢ botanix pharmaceuticals ltd

Ann: Notice of General Meeting/Proxy Form, page-40

  1. 15,359 Posts.
    lightbulb Created with Sketch. 1413
    Interesting comments you make bigfella87 (if I can use the imperial) about the efficacy of dermo phase one not continuing forward to the next level and we know how that finished. It's ditched. All of our BTX's have potential but that's it until phase 2's are done. Now, last years' initial results for BTX1801 which came with about as much fanfare as a presidential election campaign and after we were suspended for clarification but landed Dr Mark Blaskovich on the cover of a few mags is in my opinion a much bigger scientific agenda. I look forward to the trials getting on.

    What I am also cautiously optimistic about is the meeting next month with the FDA to discuss guidance. Phase 3 replicating the Australian results and I would be very happy.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
37.0¢
Change
-0.005(1.33%)
Mkt cap ! $669.7M
Open High Low Value Volume
37.5¢ 39.0¢ 37.0¢ $1.603M 4.223M

Buyers (Bids)

No. Vol. Price($)
4 378157 37.0¢
 

Sellers (Offers)

Price($) Vol. No.
37.5¢ 98000 5
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.